Search filters

List of works by Charalabos-Markos Dintsios

A distorted picture of IQWiG methodology

scientific article published on 01 January 2010

Analysis of endpoints used in marketing authorisations versus value assessments of oncology medicines in Germany.

scientific article published on 24 August 2014

Arbitration Board Setting Reimbursement Amounts for Pharmaceutical Innovations in Germany When Price Negations between Payers and Manufacturers Fail: An Empirical Analysis of 5 Years' Experience.

scientific article

Coated stents to prevent restenosis in coronary heart disease ⬇️

scientific article published on November 2, 2005

Comparison of post-authorisation measures from regulatory authorities with additional evidence requirements from the HTA body in Germany - are additional data requirements by the Federal Joint Committee justified?

scientific article

Determinants of Orphan Drug Prices in Germany

scientific article published on 01 April 2020

Different interpretation of additional evidence for HTA by the commissioned HTA body and the commissioning decision maker in Germany: whenever IQWiG and Federal Joint Committee disagree

scientific article published on 17 December 2019

Direct costs in impaired glucose regulation: results from the population-based Heinz Nixdorf Recall study

scientific article published on 25 May 2016

Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease

scientific article published on 9 December 2008

Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation.

scientific article

Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.

scientific article published on March 2010

Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial

scientific article

Failure due to formal reasons within German benefit assessment of medicinal products: the dilemma between marketing authorization and HTA

scientific article published on 20 February 2020

Implementation of a Multicomponent intervention to Prevent Physical Restraints In Nursing home residenTs (IMPRINT): study protocol for a cluster-randomised controlled trial

scientific article

Information on ethical issues in health technology assessment: how and where to find them

article

Integrating patients' views into health technology assessment: Analytic hierarchy process (AHP) as a method to elicit patient preferences

scientific article published on October 2011

Laparoscopic vs. open appendectomy: systematic review of medical efficacy and health economic analysis ⬇️

scientific article published on January 29, 2007

Letter to the editor of the Journal of Affective Disorders: Supporting the guideline's quest for real direct costs of depression care

scientific article published on 11 October 2016

Methodological problems in the method used by IQWiG within early benefit assessment of new pharmaceuticals in Germany.

scientific article published on 25 April 2018

Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany.

scientific article published on 24 January 2014

Patientenberichtete und patientengewichtete Endpunkte in der Augenheilkunde

scientific article published on 20 December 2009

Predictors of negotiated prices for new drugs in Germany

scientific article published on 25 May 2020

Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment.

scientific article published on 4 February 2016

Promoting physical activity in low back pain patients: six months follow-up of a randomised controlled trial comparing a multicomponent intervention with a low intensity intervention

scientific article published on September 2016

Quantified patient preferences for lifestyle intervention programs for diabetes prevention-a protocol for a systematic review

scholarly article by Charalabos-Markos Dintsios et al published 29 November 2018 in Systematic Reviews

Questioning patient subgroups for benefit assessment: challenging the German Gemeinsamer Bundesausschuss approach.

scientific article published in June 2014

Re: "Early benefit assessment of new drugs in Germany--results from 2011 to 2012" [Health Policy 116 (2-3) (2014) 147-153].

scientific article published on 22 October 2014

Re: Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter? (Eur J Gastroenterol Hepatol 2015, 27:1063-1068).

scientific article

Reflections on the changing face of German pharmaceutical policy: how far is Germany from value-based pricing?

scientific article published on July 2011

Relevance of Variations in the Opposing Dentition for the Functionality of Fixed and Removable Partial Dentures: A Systematic Review ⬇️

scientific article published on November 4, 2012

Some essential clarifications: IQWiG comments on two critiques of the efficiency frontier approach

scientific article published on 01 October 2010

Subgroups in the early benefit assessment of pharmaceuticals: a methodical review

scientific article published on 7 February 2015

The impact of HTA reports on health policy: a systematic review.

scientific article

Using the analytic hierarchy process to elicit patient preferences: prioritizing multiple outcome measures of antidepressant drug treatment.

scientific article published in January 2012

When suddenly the evaluation became a validation

scientific article published on 18 June 2015

[Checklist for the Development and Assessment of Cost-of-Illness Studies]

scientific article published on 18 May 2017

[Health-Related Quality of Life in the Context of Early Benefit Assessment of Drugs According to § 35a of the German Social Code Book V: A Challenging Endpoint for all the Involved Stakeholders].

scientific article

[Health-economic modeling on the use of drug-eluting stents versus coronary artery bypass graft surgery in coronary heart disease].

scientific article published on 16 May 2009

[IQWiG's methods for the cost-benefit assessment : Comparison with an international reference scenario]

scientific article published on 01 June 2010

[Intravascular brachytherapy for peripheral arterial occlusive disease: systematic review of medical efficacy and health economic modelling]

scientific article published on 01 January 2009

[Methods of health economic evaluation for health services research]

scientific article published on 23 September 2010

[Patient participation in defining and assigning importance to treatment outcomes--status quo and potential developments]

scientific article published on 01 January 2008

Paulina is supported by:

About Paulina

Help